K
Keith M. Sullivan
Researcher at Duke University
Publications - 458
Citations - 40788
Keith M. Sullivan is an academic researcher from Duke University. The author has contributed to research in topics: Transplantation & Total body irradiation. The author has an hindex of 105, co-authored 447 publications receiving 39067 citations. Previous affiliations of Keith M. Sullivan include American Cancer Society & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary Involvement.
TL;DR: The evolution of a new approach to hematopoietic stem cell transplantation for systemic sclerosis is followed and the therapeutic potential of immune restoration following autologous HSCT has deepened, and the clinical evidence for its application in scleroderma has broadened.
Journal ArticleDOI
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
Junya Kanda,Mitchell E. Horwitz,Gwynn D. Long,Cristina Gasparetto,Keith M. Sullivan,John P. Chute,Ashley Morris,Therese Hennig,Zhiguo Li,Nelson J. Chao,David A. Rizzieri +10 more
TL;DR: This series suggests that the 1-day preparative regimen is feasible, leads to successful engraftment in a high proportion of patients, and is appropriate for patients requiring immediate re-transplantation after primary graft failure following reduced-intensity transplantation.
Journal ArticleDOI
Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial
Oana Craciunescu,B. Steffey,Chris R. Kelsey,Nicole A. Larrier,Cathy J. Paarz-Largay,Robert G. Prosnitz,Nelson J. Chao,John P. Chute,Cristina Gasparetto,Mitchell E. Horwitz,Gwynn D. Long,David A. Rizzieri,Keith M. Sullivan +12 more
TL;DR: The dose to the kidneys can be attenuated while maintaining a 10% to 20% dose inhomogeneity in the lumbar spine area and with this technique, renal function has been preserved, and the study continues to enroll patients.
Journal ArticleDOI
Immunomodulation in allogeneic marrow transplantation: use of intravenous immune globulin to suppress acute graft-versus-host disease.
TL;DR: Acute and chronic graft‐versus‐host disease (GVHD) and associated infections remain critical barriers to the wider application of allogeneic blood or marrow transplantation, especially among patients given HLA‐disparate grafts.
Journal ArticleDOI
Impact of a Randomized, Controlled Trial of Liberal vs Conservative Hospital Discharge Criteria on Energy, Protein, and Fluid Intake in Patients Who Received Marrow Transplants
Jean M. Stern,Barbara Bruemmer,Carol M. Moinpour,Keith M. Sullivan,Polly Lenssenms,Saundra N. Aker +5 more
TL;DR: Because of continued high-risk nutrition status and potential for rapid change in medical status, nutrition assessment and counseling are necessary in both the hospital and ambulatory setting to promote resumption of oral intake and discontinuation of i.v. fluids.